Journals / Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi / 2020 / Cilt: 13 - Sayı: 3

Diabetes Management in Individuals with Severe Mental Illness and the Role of the Psychiatric Nurse

Kronik Ruhsal Hastalığı Olan Bireylerde Diyabet Yönetimi ve Psikiyatri Hemşiresinin Rolü

Pages
195–199
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is to shed light on the prevalence and the management of diabetes in individuals with severe mental illness and on the roles of psychiatric nurses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes Mellitus is a complex metabolic disorder characterized by resistant hyperglycemia.
📊
Key Findings & Data:In addition, the risk of diabetes is increased due to the side effects of second generation antipsychotic drugs, such as weight gain, glucose metabolism disorders, used by individuals with severe mental illness.
💡
Conclusion & Impact:The purpose of this review is to shed light on the prevalence and the management of diabetes in individuals with severe mental illness and on the roles of psychiatric nurses.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Diyabetes Mellitus · Psikiyatri Hemşireliği · Ruhsal Hastalık

Abstract

Diabetes Mellitus is a complex metabolic disorder characterized by resistant hyperglycemia. The prevalence of diabetes in individuals with severe mental illness is higher than in the healthy population. Diabetes Mellitus is known to develop due to several factors including genetics and lifestyle. In addition, the risk of diabetes is increased due to the side effects of second generation antipsychotic drugs, such as weight gain, glucose metabolism disorders, used by individuals with severe mental illness. Promoting a healthy lifestyle in diabetes management, screening and monitoring patients is an important part of the treatment. This increase in the rates of diabetes in individuals with severe mental illness and the difficulties that patients have in managing both illness require new approaches in health care. The purpose of this review is to shed light on the prevalence and the management of diabetes in individuals with severe mental illness and on the roles of psychiatric nurses.

Özet

Diabetus mellitus dirençli hiperglisemi ile karakterize kompleks metabolik bir bozukluktur. Kronik ruhsal hastalığı olan bireylerde diyabet görülme oranı sağlıklı popülasyona göre daha yüksektir. Genetik ve yaşam biçimini içeren birçok faktöre bağlı olarak geliştiği bilinen tip 2 diyabetin, ikinci kuşak antipsikotik ilaçların kilo artışı, glikoz metabolizma bozuklukları gibi yan etkisi nedeniyle kronik ruhsal hastalığı olan bireylerde görülme riski artmaktadır. Diyabet yönetiminde sağlıklı yaşam biçimini teşvik etme, tarama ve izleme tedavinin önemli parçasıdır. Kronik ruhsal hastalığı olan bireylerde diyabet oranlarındaki bu artış ve hastaların her iki hastalığı yönetmelerinde yaşadığı zorluklar sağlık bakımında yeni yaklaşımları gerektirmektedir. Bu derlemenin amacı kronik ruhsal hastalığı olan bireylerde diyabet sıklığının, yönetiminin nasıl olduğuna ve psikiyatri hemşirelerinin rollerine ışık tutmaktır.

🔖

Cite This Article

İNCE, S. Ç., GÜNÜŞEN, N. (2020). Diabetes Management in Individuals with Severe Mental Illness and the Role of the Psychiatric Nurse. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi, Cilt: 13 - Sayı: 3, 195–199. https://ajindex.com/articles/150568

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Türkiye Diyabet Vakfı. Diyabet tanı ve tedavi rehberi 2017. 2017; 14–15
  2. Coşansu G. Diyabet: Küresel bir salgın hastalık. Okmeydanı Tıp Derg. 2015;31(ek sayı):1–6
  3. World Health Organization. World diabetes day. [online]. 2013;2(4): 123-124. URL: http://who.int/health-topics/diabetes. 10 Ekim 2013
  4. International Diabetes Federation. Diabetes atlas [online]. 2013;12-40. URL: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/19-atlas-6th-edition.html. 27 Mayıs 2013
  5. Türkiye İstatistik Kurumu. İstatistiklerle Türkiye [online]. 2015; 111-112. URL: http://www.tuik.gov.tr. 12 Haziran 2015
  6. Wykes TL, Lee AA, Bourassa K, Kitchen KA, McKibbin CL. Diabetes knowledge among adults with serious mental illness and comorbid diabetes mellitus. Arch Psychiatr Nurs. 2017;31(2):190–6
  7. İstek N, Karakurt P. Global bir sağlık sorunu: tip 2 diyabet ve öz-bakım yönetimi. JAREN. 2018;4(3):179–82
  8. Vaez K, Diegel-Vacek L, Ryan C, Martyn-Nemeth P. Evaluating diabetes care for patients with serious mental illness using the chronic care model. Heal Serv Res Manag Epidemiol. 2017;4:1-7
  9. Vancampfort D, Correlli CU, Gallin B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis. World Psychiatry. 2016;15(2):166–74
  10. Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017;16:30–40
  11. Kurdyak P, Vigod S, Duchen R, Jacob B, Stukel T, Kiran T. Diabetes quality of care and outcomes: Comparison of individuals with and without schizophrenia. Gen Hosp Psychiatry. 2017;46:7–13
  12. Holt RIG. Diabetes in psychiatric disease. Med (United Kingdom). 2015;43(1):51–3
  13. Vinogradova Y, Coupland C, Hippisley-Cox J, Whyte S, Penny C. Effects of severe mental illness on survival of people with diabetes. Br J Psychiatry. 2010;197(4):272–7
  14. Stubbs B, Vancampfort D, De Hert M, Mitchell AJ. The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand. 2015;132(2):144–57
  15. Subashini R, Deepa M, Padmavati R, Thara R, Mohan V. Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (CURES-104). J P